Drugs / BAX 802
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02895945 | Dec 2016 → Jan 2021 | hemophilia A | Baxalta now part of Shire | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAX 802 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02895945 ↗ |
| Modality | Protein / enzyme biologic | “Biological: Antihemophilic Factor (Recombinant), Porcine Sequence (BAX 802)” NCT02895945 ↗ |